Keyphrases
Pediatric Atopic Dermatitis
100%
Dupilumab
100%
Pediatric Patients
42%
Investigator's Global Assessment
42%
Atopic Dermatitis
28%
Clinical Trials
14%
Effective Treatment
14%
Retrospective Chart Review
14%
Phase II Trial
14%
Adult Patients
14%
Optimal Dose
14%
Dosing Regimen
14%
Infection Risk
14%
Safety Profile
14%
Lack of Information
14%
Treatment Duration
14%
Potential Side Effects
14%
Injection Site Reaction
14%
Private Practice
14%
Body Surface Area
14%
Conjunctivitis
14%
Efficacy Profile
14%
Off-label Use
14%
Moderate-to-severe Atopic Dermatitis
14%
Half-dose
14%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Dupilumab
100%
Side Effect
28%
Clinical Trial
14%
Infection
14%
Injection Site Reaction
14%
Off-Label Use
14%